Minoxidil: Global Markets
Report Scope
The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the competitive landscape. Regulatory scenarios, drivers, restraints, and opportunities are covered.
For this report, the market is segmented based on type, form, application and geography or region. Based on type, the market in this report is segmented into 5%, 2% and 10% Minoxidil. The forms of Minoxidil are topical and oral. In terms of applications, the report covers alopecia and chronic diseases.
In terms of regional analysis, the market is segmented into North America, Europe, Asia-Pacific, and ROW, with detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, and India. For market estimates, data are provided for 2019 as the base year, with estimates for 2020 and forecast values for 2025.
Report Includes
The report analyzes the market trends of Minoxidil with data from 2019, estimates from 2020, and projections of compound annual growth rates (CAGRs) through the forecast period of 2020 through 2025). The report will highlight the current and future market potential of Minoxidil along with an analysis of the competitive landscape. Regulatory scenarios, drivers, restraints, and opportunities are covered.
For this report, the market is segmented based on type, form, application and geography or region. Based on type, the market in this report is segmented into 5%, 2% and 10% Minoxidil. The forms of Minoxidil are topical and oral. In terms of applications, the report covers alopecia and chronic diseases.
In terms of regional analysis, the market is segmented into North America, Europe, Asia-Pacific, and ROW, with detailed analysis of the market in major countries such as the U.S., Germany, the U.K., Italy, France, Spain, Japan, China, and India. For market estimates, data are provided for 2019 as the base year, with estimates for 2020 and forecast values for 2025.
Report Includes
- 11 data tables and 24 additional tables
- An overview of the global market for minoxidil
- Estimation of the market size and analyses of market trends, with data from 2018, 2019, 2020, and projection of CAGR through 2025
- Market share analysis of minoxidil by type, form, application, and region, and evaluation of market size and forecast, and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Coverage of ongoing scientific discoveries and technological advances and insights into marketed and pipeline (R&D) products, product recalls, and reimbursement policies
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players, including Dr. Reddy’s Laboratories, Cipla, Johnson & Johnson, Novartis AG, Pfizer Inc., and Teva Pharmaceutical Industries Ltd.
CHAPTER 1 INTRODUCTION
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market Size
CHAPTER 3 MARKET OVERVIEW
Market Dynamics
Drivers
Market Restraints
Market Opportunities
CHAPTER 4 REGULATORY AND PATENT LANDSCAPE
Regulatory Landscape
U.S.
Europe
Asia-Pacific
Patent Reviews
CHAPTER 5 MARKET TRENDS
Product Pipeline
Future Potential Treatments
Strategies and Developments
CHAPTER 6 IMPACT OF COVID-19 ON MARKET
Overview
COVID-19 Crisis
Short-Term Impact on Pharmaceutical Industry
Long-Term Impact
Impact on Supply Chain
Impact of COVID-19 on the Market for Minoxidil
Current Outlook
CHAPTER 7 MARKET BREAKDOWN BY TYPE
2% Minoxidil
5% Minoxidil
10% Minoxidil
CHAPTER 8 MARKET BREAKDOWN BY FORM
Topical
Oral Minoxidil
CHAPTER 9 MARKET BREAKDOWN BY APPLICATION
Alopecia
Other Chronic Diseases
CHAPTER 10 MARKET BREAKDOWN BY REGION
Overview
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
India
China
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
CHAPTER 11 COMPANY PROFILES
APOTEX INC.
CIPLA
DR. REDDY'S LABORATORIES LTD.
JOHNSON & JOHNSON
MYLAN (VIATRIS)
NOVARTIS AG
PERRIGO COMPANY PLC
PFIZER INC.
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
CHAPTER 12 APPENDIX: ACRONYMS USED IN THIS REPORT
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
CHAPTER 2 SUMMARY AND HIGHLIGHTS
Global Market Size
CHAPTER 3 MARKET OVERVIEW
Market Dynamics
Drivers
Market Restraints
Market Opportunities
CHAPTER 4 REGULATORY AND PATENT LANDSCAPE
Regulatory Landscape
U.S.
Europe
Asia-Pacific
Patent Reviews
CHAPTER 5 MARKET TRENDS
Product Pipeline
Future Potential Treatments
Strategies and Developments
CHAPTER 6 IMPACT OF COVID-19 ON MARKET
Overview
COVID-19 Crisis
Short-Term Impact on Pharmaceutical Industry
Long-Term Impact
Impact on Supply Chain
Impact of COVID-19 on the Market for Minoxidil
Current Outlook
CHAPTER 7 MARKET BREAKDOWN BY TYPE
2% Minoxidil
5% Minoxidil
10% Minoxidil
CHAPTER 8 MARKET BREAKDOWN BY FORM
Topical
Oral Minoxidil
CHAPTER 9 MARKET BREAKDOWN BY APPLICATION
Alopecia
Other Chronic Diseases
CHAPTER 10 MARKET BREAKDOWN BY REGION
Overview
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia-Pacific
Japan
India
China
Australia
South Korea
Rest of Asia-Pacific
Rest of the World
CHAPTER 11 COMPANY PROFILES
APOTEX INC.
CIPLA
DR. REDDY'S LABORATORIES LTD.
JOHNSON & JOHNSON
MYLAN (VIATRIS)
NOVARTIS AG
PERRIGO COMPANY PLC
PFIZER INC.
TAISHO PHARMACEUTICAL HOLDINGS CO. LTD.
TEVA PHARMACEUTICAL INDUSTRIES LTD.
CHAPTER 12 APPENDIX: ACRONYMS USED IN THIS REPORT
LIST OF TABLES
Summary Table: Global Market for Minoxidil, by Region, Through 2025
Table 1: Global Elderly (60+) Population Growth, 1980-2020
Table 2: Drug Alternatives for Alopecia
Table 3: Natural Alternatives for Alopecia
Table 4: Patents Issued for Minoxidil
Table 5: U.S. Patents Issued for Hair Loss Treatment
Table 6: Minoxidil Pipeline
Table 7: Potential Treatment Options for Types of Alopecia
Table 8: Breakthrough Therapy Designation, 2018-2020
Table 9: Global Market for 2% Minoxidil Solution, by Region, Through 2025
Table 10: Global Market for 5% Minoxidil Solution, by Region, Through 2025
Table 11: Global Market for 10% Minoxidil Solution, by Region, Through 2025
Table 12: Global Market for Topical Minoxidil, by Region, Through 2025
Table 13: Global Market for Oral Minoxidil, by Region, Through 2025
Table 14: Classification of Alopecia
Table 15: Global Market for Minoxidil in the Treatment of Alopecia, by Region, Through 2025
Table 16: Global Market for Minoxidil in the Treatment of Other Chronic Diseases, by Region, Through 2025
Table 17: North American Market for Minoxidil, by Country, Through 2025
Table 18: European Market for Minoxidil, by Country, Through 2025
Table 19: Asia-Pacific Market for Minoxidil, by Country, Through 2025
Table 20: Apotex: Minoxidil Product Portfolio
Table 21: Cipla: Minoxidil Product Portfolio
Table 22: Dr. Reddy’s Laboratories: Minoxidil Product Portfolio
Table 23: Dr. Reddy’s Laboratories: Key Developments, 2018
Table 24: Johnson & Johnson: Minoxidil Product Portfolio
Table 25: Johnson & Johnson: Key Developments, 2018
Table 26: Mylan: Minoxidil Product Portfolio.
Table 27: Sandoz: Minoxidil Product Portfolio
Table 28: Perrigo Company Plc: Minoxidil Product Portfolio
Table 29: Perrigo Company Plc: Key Developments, 2018
Table 30: Pfizer: Minoxidil Product Portfolio
Table 31: Taisho Pharmaceutical: Minoxidil Products
Table 32: Teva Pharmaceutical: Minoxidil Products
Table 33: Teva Pharmaceutical: Key Developments
Table 34: Acronyms Used in This Report
Summary Table: Global Market for Minoxidil, by Region, Through 2025
Table 1: Global Elderly (60+) Population Growth, 1980-2020
Table 2: Drug Alternatives for Alopecia
Table 3: Natural Alternatives for Alopecia
Table 4: Patents Issued for Minoxidil
Table 5: U.S. Patents Issued for Hair Loss Treatment
Table 6: Minoxidil Pipeline
Table 7: Potential Treatment Options for Types of Alopecia
Table 8: Breakthrough Therapy Designation, 2018-2020
Table 9: Global Market for 2% Minoxidil Solution, by Region, Through 2025
Table 10: Global Market for 5% Minoxidil Solution, by Region, Through 2025
Table 11: Global Market for 10% Minoxidil Solution, by Region, Through 2025
Table 12: Global Market for Topical Minoxidil, by Region, Through 2025
Table 13: Global Market for Oral Minoxidil, by Region, Through 2025
Table 14: Classification of Alopecia
Table 15: Global Market for Minoxidil in the Treatment of Alopecia, by Region, Through 2025
Table 16: Global Market for Minoxidil in the Treatment of Other Chronic Diseases, by Region, Through 2025
Table 17: North American Market for Minoxidil, by Country, Through 2025
Table 18: European Market for Minoxidil, by Country, Through 2025
Table 19: Asia-Pacific Market for Minoxidil, by Country, Through 2025
Table 20: Apotex: Minoxidil Product Portfolio
Table 21: Cipla: Minoxidil Product Portfolio
Table 22: Dr. Reddy’s Laboratories: Minoxidil Product Portfolio
Table 23: Dr. Reddy’s Laboratories: Key Developments, 2018
Table 24: Johnson & Johnson: Minoxidil Product Portfolio
Table 25: Johnson & Johnson: Key Developments, 2018
Table 26: Mylan: Minoxidil Product Portfolio.
Table 27: Sandoz: Minoxidil Product Portfolio
Table 28: Perrigo Company Plc: Minoxidil Product Portfolio
Table 29: Perrigo Company Plc: Key Developments, 2018
Table 30: Pfizer: Minoxidil Product Portfolio
Table 31: Taisho Pharmaceutical: Minoxidil Products
Table 32: Teva Pharmaceutical: Minoxidil Products
Table 33: Teva Pharmaceutical: Key Developments
Table 34: Acronyms Used in This Report
LIST OF FIGURES
Summary Figure: Global Market for Minoxidil, by Type, 2019-2025
Figure 1: Trends in Global Elderly (60+ Years) Population Growth, 1990-2100
Figure 2: Impact of COVID-19 on Pharmaceutical Industry
Figure 3: Global Market for 2% Minoxidil Solution, 2019-2025
Figure 4: Global Market for 5% Minoxidil Solution, 2019-2025
Figure 5: Global Market for 10% Minoxidil Solution, 2019-2025
Figure 6: Global Market for Topical Minoxidil, 2019-2025
Figure 7: Global Market for Oral Minoxidil, 2019-2025
Figure 8: Global Market for Minoxidil in the Treatment of Alopecia, 2019-2025
Figure 9: Global Market for Minoxidil in the Treatment of Other Chronic Diseases, 2019-2025
Figure 10: Global Market for Minoxidil, by Region, 2019-2025
Figure 11: Global Market Shares for Minoxidil, by Region, 2019
Figure 12: North American Market for Minoxidil, 2019-2025
Figure 13: European Market for Minoxidil, 2019-2025
Figure 14: Asia-Pacific Market for Minoxidil, 2019-2025
Figure 15: Rest of World Market for Minoxidil, 2019-2025
Summary Figure: Global Market for Minoxidil, by Type, 2019-2025
Figure 1: Trends in Global Elderly (60+ Years) Population Growth, 1990-2100
Figure 2: Impact of COVID-19 on Pharmaceutical Industry
Figure 3: Global Market for 2% Minoxidil Solution, 2019-2025
Figure 4: Global Market for 5% Minoxidil Solution, 2019-2025
Figure 5: Global Market for 10% Minoxidil Solution, 2019-2025
Figure 6: Global Market for Topical Minoxidil, 2019-2025
Figure 7: Global Market for Oral Minoxidil, 2019-2025
Figure 8: Global Market for Minoxidil in the Treatment of Alopecia, 2019-2025
Figure 9: Global Market for Minoxidil in the Treatment of Other Chronic Diseases, 2019-2025
Figure 10: Global Market for Minoxidil, by Region, 2019-2025
Figure 11: Global Market Shares for Minoxidil, by Region, 2019
Figure 12: North American Market for Minoxidil, 2019-2025
Figure 13: European Market for Minoxidil, 2019-2025
Figure 14: Asia-Pacific Market for Minoxidil, 2019-2025
Figure 15: Rest of World Market for Minoxidil, 2019-2025
